LPCAT2 and Alzheimer disease: To explore potential drivers of this APOE genotype‐ and sex‐specific association, blood transcriptomic analysis identified LPCAT2 expression as correlating with both heightened pain susceptibility and progression from MCI to AD, most notably in non‐E4 males.